Ontology Browser

fetal alcohol spectrum disorder (DOID:0050696)
Annotations: Rat: (8) Mouse: (8) Human: (8) Chinchilla: (8) Bonobo: (8) Dog: (8) Squirrel: (7)
Parent Terms Term With Siblings Child Terms
Alcohol-Induced Disorders, Nervous System +   
alcoholic cardiomyopathy  
Alcoholic Liver Diseases +   
alcoholic pancreatitis  
alcoholic psychosis 
Attention Deficit and Disruptive Behavior Disorders +   
attention deficit hyperactivity disorder +   
chorioamnionitis +   
cocoon syndrome  
communication disorder +   
conduct disorder  
developmental coordination disorder  
Diabetic Embryopathy  
eating disorder +   
Echogenic Bowel 
fetal alcohol spectrum disorder +   
An umbrella term used to describe a pattern of disabilities and abnormalities that result from fetal exposure to ETHANOL during pregnancy. It encompasses a phenotypic range that can vary greatly between individuals, but reliably includes one or more of the following: characteristic facial dysmorphism, FETAL GROWTH RETARDATION, central nervous system abnormalities, cognitive and/or behavioral dysfunction, BIRTH DEFECTS. The level of maternal alcohol consumption does not necessarily correlate directly with disease severity.
fetal erythroblastosis +   
Fetal Growth Retardation +   
Fetal Hypoxia  
Fetal Macrosomia +   
fetal nicotine spectrum disorder 
Fetal Nutrition Disorders  
intellectual disability +   
learning disability +   
meconium aspiration syndrome  
Multiple Pterygium Syndrome, Lethal Type  
Nuchal Cord 
oppositional defiant disorder  
stereotypic movement disorder +   
tic disorder +   

Exact Synonyms: FAE (Fetal Alcohol Effects) ;   FAEs (Fetal Alcohol Effects) ;   FASD ;   FASDs ;   Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction ;   alcohol related birth defects ;   fetal alcohol syndrome
Primary IDs: MESH:D063647
Alternate IDs: RDO:0015823
Definition Sources: MESH:D063647, http://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder, http://www.cdc.gov/ncbddd/fasd/facts.html

paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.